Suchergebnisse - "Mirmosayyeb, Omid"

PubPharm (11)

1

Efficacy and safety of rituximab in multiple sclerosis : a systematic review and meta-analysis

enthalten in: Acta neurologica Belgica | 2023

von Nabizadeh, F. | Ahmadabad, M. | Mohamadi, M. | +4

2

Efficacy and safety of rituximab in multiple sclerosis: a systematic review and meta-analysis

enthalten in: Acta neurologica Belgica | 2023

von Nabizadeh, F. | Ahmadabad, M. | Mohamadi, M. | +4

3

Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis : A population-based study

enthalten in: Multiple sclerosis and related disorders | 2023

von Barzegar, M. | Manteghinejad, A. | Afshari-Safavi, A. | +8

4

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population : a population-based study

enthalten in: BMC neurology | 2022

von Barzegar, M. | Manteghinejad, A. | Bagherieh, S. | +5

5

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

enthalten in: BMC neurology | 2022

von Barzegar, M. | Manteghinejad, A. | Bagherieh, S. | +5

6

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

enthalten in: BMC neurology | 2022

von Barzegar, M. | Manteghinejad, A. | Bagherieh, S. | +5

7

Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls

enthalten in: Research in pharmaceutical sciences | 2022

von Yahyazadeh, S. | Esmaeil, N. | Shaygannejad, V. | +1

8

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD) : A systematic review and meta-analysis

enthalten in: Multiple sclerosis and related disorders | 2022

von Barzegar, M. | Mirmosayyeb, O. | Ebrahimi, N. | +5

9

Rituximab and glatiramer acetate in secondary progressive multiple sclerosis : A randomized clinical trial

enthalten in: Acta neurologica Scandinavica | 2021

von Cheshmavar, M. | Mirmosayyeb, O. | Badihian, N. | +2

10

Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD) : A systematic review and meta-analysis

enthalten in: Autoimmunity reviews | 2021

von Mirmosayyeb, O. | Shaygannejad, V. | Barzegar, M. | +2